Michael A Carducci


If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michael A Carducci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Castration Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Androgens Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: The CheckMate 016 study (Journal for ImmunoTherapy of Cancer (2018) 6 (109) DOI: 10.1186/s40425-018-0420-0)

Amin, A., Plimack, E. R., Ernstoff, M. S., Lewis, L. D., Bauer, T. M., McDermott, D. F., Carducci, M. A., Kollmannsberger, C., Rini, B. I., Heng, D. Y. C., Knox, J., Voss, M. H., Spratlin, J., Berghorn, E., Yang, L. & Hammers, H. J., Mar 14 2019, In : Journal for immunotherapy of cancer. 7, 1, 73.

Research output: Contribution to journalComment/debate

Open Access
Renal Cell Carcinoma

Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype

Shenderov, E., Isaacsson Velho, P., Awan, A. H., Wang, H., Mirkheshti, N., Lotan, T. L., Carducci, M. A., Pardoll, D. M., Eisenberger, M. A. & Antonarakis, E. S., Jan 1 2019, In : Prostate. 79, 13, p. 1572-1579 8 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Prostate-Specific Antigen
Renal Cell Carcinoma
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
Prospective Studies
Neoplasm Metastasis

Muscadine grape skin extract inhibits prostate cancer cells by inducing cell-cycle arrest, and decreasing migration through heat shock protein 40

Ignacio, D. N., Mason, K. D., Hackett-Morton, E. C., Albanese, C., Ringer, L., Wagner, W. D., Wang, P. C., Carducci, M. A., Kachhap, S., Paller, C., Mendonca, J., Li-Ying Chan, L., Lin, B., Hartle, D. K., Green, J. E., Brown, C. A. & Hudson, T. S., Jan 1 2019, In : Heliyon. 5, 1, e01128.

Research output: Contribution to journalArticle

HSP40 Heat-Shock Proteins
Cell Cycle Checkpoints
Prostatic Neoplasms

Phase II trial of eribulin in patients with metastatic hormone refractory prostate cancer: A trial of the ECOG-ACRIN cancer research group (E5805)

Stein, M. N., Chen, Y. H., Carducci, M. A., Hudes, G. R., Lerma, P. M., Tan, W. W., Dalune, R., Rowland, K. M., Kuzel, T. M. & Dipaola, R. S., Jan 1 2019, In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Drug Therapy